| PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma (NCT07700121) | Abramson Cancer Center at Penn Medicine | 2026-10-01 |
| Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma (NCT07059611) | Abramson Cancer Center at Penn Medicine | 2026-09-01 |
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs (NCT07578467) | Abramson Cancer Center at Penn Medicine | 2026-08-31 |
| Genetic Information for Families After Tumor Testing Study (NCT07517666) | Abramson Cancer Center at Penn Medicine | 2026-07-15 |
| Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) (NCT06770855) | Abramson Cancer Center at Penn Medicine | 2026-06-30 |
| Low Dose Radiotherapy for Osteoarthritis (NCT07715188) | Abramson Cancer Center at Penn Medicine | 2026-06-24 |
| Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas (NCT07478848) | Abramson Cancer Center at Penn Medicine | 2026-05-29 |
| Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE) (NCT07454499) | Abramson Cancer Center at Penn Medicine | 2026-05-13 |
| Allergy Delabeling in Antibiotic Stewardship - Intervention (NCT07133074) | Abramson Cancer Center at Penn Medicine | 2026-04-20 |
| Short Course Radiotherapy (NCT07147179) | Abramson Cancer Center at Penn Medicine | 2026-04-02 |
| A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials (NCT07040891) | Abramson Cancer Center at Penn Medicine | 2026-02-01 |
| Comparing Numbing Techniques in Mohs Micrographic Surgery (NCT07222241) | Abramson Cancer Center at Penn Medicine | 2026-01-27 |
| A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship (NCT07655934) | Abramson Cancer Center at Penn Medicine | 2026-01-20 |
| Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema (NCT06837480) | Abramson Cancer Center at Penn Medicine | 2026-01-15 |
| Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit (NCT07199517) | Abramson Cancer Center at Penn Medicine | 2026-01-12 |
| Allergy Delabeling in Antibiotic Stewardship - Evaluations (NCT06967467) | Abramson Cancer Center at Penn Medicine | 2025-12-01 |
| Safe and Explainable AI (NCT06694181) | Abramson Cancer Center at Penn Medicine | 2025-11-29 |
| Head Stabilization in Whole Brain RT (NCT06776406) | Abramson Cancer Center at Penn Medicine | 2025-10-14 |
| FTT PET/CT in Pancreatic Neuroendocrine Tumors (NCT07114939) | Abramson Cancer Center at Penn Medicine | 2025-10-01 |
| AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake (NCT07230795) | Abramson Cancer Center at Penn Medicine | 2025-09-29 |
| Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma (NCT07082439) | Abramson Cancer Center at Penn Medicine | 2025-09-10 |
| Vape Use Among Younger & Older Smokers (NCT07214168) | Abramson Cancer Center at Penn Medicine | 2025-09-05 |
| Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3) (NCT07471958) | Abramson Cancer Center at Penn Medicine | 2025-09-02 |
| Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology (NCT06955468) | Abramson Cancer Center at Penn Medicine | 2025-07-21 |
| Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology (NCT07078409) | Abramson Cancer Center at Penn Medicine | 2025-07-14 |
| Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support (NCT07048496) | Abramson Cancer Center at Penn Medicine | 2025-07-05 |
| Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70) (NCT06870617) | Abramson Cancer Center at Penn Medicine | 2025-07-01 |
| Increasing Screening for Cancer Using EHR-Nudges Replication (NCT06995703) | Abramson Cancer Center at Penn Medicine | 2025-06-02 |
| Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy (NCT06747845) | Abramson Cancer Center at Penn Medicine | 2025-05-07 |
| Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma (NCT06613841) | Abramson Cancer Center at Penn Medicine | 2025-05-01 |
| Healthy Volunteers Study (NCT06962059) | Abramson Cancer Center at Penn Medicine | 2025-04-21 |
| Communication Strategies to Increase HPV Vaccination Intention (NCT06784960) | Abramson Cancer Center at Penn Medicine | 2025-02-06 |
| Hypofractionated WPPT With HDR Boost (NCT06591819) | Abramson Cancer Center at Penn Medicine | 2025-01-15 |
| Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature (NCT06332131) | Abramson Cancer Center at Penn Medicine | 2025-01-15 |
| BHB & CAR-T for Lymphomas (NCT06610344) | Abramson Cancer Center at Penn Medicine | 2025-01-07 |
| Utility of Random Biopsies in Patients With Inflammatory Bowel Disease (NCT06560021) | Abramson Cancer Center at Penn Medicine | 2025-01-03 |
| Assessing Perceptions of ML Explanations by Medical Oncologists (NCT06699615) | Abramson Cancer Center at Penn Medicine | 2024-12-02 |
| QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer (NCT06551116) | Abramson Cancer Center at Penn Medicine | 2024-10-10 |
| Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers (NCT06372899) | Abramson Cancer Center at Penn Medicine | 2024-10-02 |
| Young Adults and Low Nicotine Cigarettes (NCT03699865) | Abramson Cancer Center at Penn Medicine | 2024-10-01 |
| Community Support Program for Lung Cancer Screening Volume II (NCT06628167) | Abramson Cancer Center at Penn Medicine | 2024-10-01 |
| Epcoritamab-CAR T Cells for Large B-cell Lymphomas (NCT06458439) | Abramson Cancer Center at Penn Medicine | 2024-09-24 |
| Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis (NCT06578637) | Abramson Cancer Center at Penn Medicine | 2024-09-20 |
| Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines (NCT06559462) | Abramson Cancer Center at Penn Medicine | 2024-09-19 |
| The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers (NCT06264154) | Abramson Cancer Center at Penn Medicine | 2024-08-26 |
| FAPI-74 PET/CT in Adults With Fibrosis (NCT06413355) | Abramson Cancer Center at Penn Medicine | 2024-07-16 |
| Integrating Telehealth to Advance Lung Cancer Screening (NCT06638554) | Abramson Cancer Center at Penn Medicine | 2024-07-09 |
| Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer (NCT06436248) | Abramson Cancer Center at Penn Medicine | 2024-07-01 |
| Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC) (NCT06337162) | Abramson Cancer Center at Penn Medicine | 2024-05-01 |
| Virtual Reality to Promote Relaxation Prior to Simulation (NCT06318338) | Abramson Cancer Center at Penn Medicine | 2024-04-08 |
| [18F]FES PET/.CT in Uterine Cancer (NCT05916196) | Abramson Cancer Center at Penn Medicine | 2024-04-05 |
| Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial] (NCT06125743) | Abramson Cancer Center at Penn Medicine | 2024-03-29 |
| Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer (NCT06019988) | Abramson Cancer Center at Penn Medicine | 2024-03-11 |
| Social Media Anti-Vaping Messages to Reduce ENDS Use Among Sexual and Gender Minority Teens (NCT06308081) | Abramson Cancer Center at Penn Medicine | 2024-02-21 |
| Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors (NCT06211413) | Abramson Cancer Center at Penn Medicine | 2024-02-07 |
| Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery (NCT06204159) | Abramson Cancer Center at Penn Medicine | 2024-02-01 |
| Nudge to Gynecologic Oncology (NCT06451263) | Abramson Cancer Center at Penn Medicine | 2024-01-19 |
| Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES (NCT05968898) | Abramson Cancer Center at Penn Medicine | 2024-01-09 |
| Prostate Tissue BioBank (NCT06659614) | Abramson Cancer Center at Penn Medicine | 2024-01-01 |
| Increasing Screening for Cancer Using EHR-Nudges (NCT06177795) | Abramson Cancer Center at Penn Medicine | 2023-12-18 |
| A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research (NCT05852860) | Abramson Cancer Center at Penn Medicine | 2023-12-01 |
| Comparison of Apixaban Versus Enoxaparin (NCT06243510) | Abramson Cancer Center at Penn Medicine | 2023-11-24 |
| Project Looking-Glass Evaluation (NCT06056063) | Abramson Cancer Center at Penn Medicine | 2023-11-19 |
| Assessment of Geriatric Evaluations Impact on New AML Guidance (NCT05909501) | Abramson Cancer Center at Penn Medicine | 2023-10-25 |
| Penn Medicine Biobank Return of Results Program (NCT06089954) | Abramson Cancer Center at Penn Medicine | 2023-10-20 |
| Increasing Adherence to Lung Cancer Screening (NCT05832008) | Abramson Cancer Center at Penn Medicine | 2023-10-18 |
| Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts (NCT05787249) | Abramson Cancer Center at Penn Medicine | 2023-10-04 |
| FES BPET-DBT in Newly Diagnosed Breast Cancer (NCT05659797) | Abramson Cancer Center at Penn Medicine | 2023-10-02 |
| Behavioral Relaxation Approaches for Insomnia in Lung Cancer Patients (NCT04318249) | Abramson Cancer Center at Penn Medicine | 2023-09-30 |
| Staying Healthy With Follow-up Care: A Mobile Chatbot Feasibility Study for AYA Cancer Survivors (NCT05863702) | Abramson Cancer Center at Penn Medicine | 2023-09-11 |
| Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana (NCT05952141) | Abramson Cancer Center at Penn Medicine | 2023-09-01 |
| Lung Cancer Screening Eligibility Assessment (NCT06133816) | Abramson Cancer Center at Penn Medicine | 2023-07-31 |
| Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy (NCT04691817) | Abramson Cancer Center at Penn Medicine | 2023-07-25 |
| Limited-duration Teclistamab (NCT05932680) | Abramson Cancer Center at Penn Medicine | 2023-07-05 |
| Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening (NCT05693649) | Abramson Cancer Center at Penn Medicine | 2023-06-07 |
| QOL and Sarcopenia in Patients With Ascites (NCT05726747) | Abramson Cancer Center at Penn Medicine | 2023-05-23 |
| ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy (NCT05318027) | Abramson Cancer Center at Penn Medicine | 2023-05-22 |
| Telehealth Based Synchronous Navigation to Improve Molecularly-Informed Care for Patients With Lung Cancer (NCT05790460) | Abramson Cancer Center at Penn Medicine | 2023-05-08 |
| Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma (NCT05733715) | Abramson Cancer Center at Penn Medicine | 2023-05-03 |
| Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition (NCT05721326) | Abramson Cancer Center at Penn Medicine | 2023-05-01 |
| Second Window Indocyanine Green for All Nervous System Tumors (NCT05746104) | Abramson Cancer Center at Penn Medicine | 2023-03-31 |
| Using Surveys to Examine the Association of Exposure to ML Mortality Risk Predictions With Medical Oncologists' Prognostic Accuracy and Decision-making (NCT06463977) | Abramson Cancer Center at Penn Medicine | 2023-03-13 |
| The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients (NCT05226078) | Abramson Cancer Center at Penn Medicine | 2023-03-01 |
| FTT PET/CT in Metastatic Prostate Cancer (NCT05242744) | Abramson Cancer Center at Penn Medicine | 2023-03-01 |
| Collection of Circulating Biomarkers in Pancreatic Cancer (NCT05743049) | Abramson Cancer Center at Penn Medicine | 2023-02-27 |
| Improve Outcomes for Older Allogeneic Transplant Recipients (NCT05612789) | Abramson Cancer Center at Penn Medicine | 2023-02-15 |
| Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma (NCT05496036) | Abramson Cancer Center at Penn Medicine | 2023-02-13 |
| Community Support Program for Lung Cancer Screening (NCT06207435) | Abramson Cancer Center at Penn Medicine | 2023-02-10 |
| Shared Decision-making and Colorectal Cancer Screening (NCT04748380) | Abramson Cancer Center at Penn Medicine | 2023-01-18 |
| WBSI Guided Personalized Delivery of TTFields (NCT05086497) | Abramson Cancer Center at Penn Medicine | 2023-01-15 |
| Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) (NCT03760575) | Abramson Cancer Center at Penn Medicine | 2023-01-10 |
| Project PLUS Lung Cancer Screening Promotion (NCT05937399) | Abramson Cancer Center at Penn Medicine | 2022-12-02 |
| Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer (NCT05590962) | Abramson Cancer Center at Penn Medicine | 2022-11-09 |
| Vaccine Responses in Cancer (NCT06605625) | Abramson Cancer Center at Penn Medicine | 2022-11-04 |
| Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care (NCT05331625) | Abramson Cancer Center at Penn Medicine | 2022-11-03 |
| Head Stabilization of Healthy Volunteers (NCT07116759) | Abramson Cancer Center at Penn Medicine | 2022-10-09 |
| Role of the Immune Environment in Response to Therapy in Breast Cancer (NCT05396612) | Abramson Cancer Center at Penn Medicine | 2022-10-03 |
| eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (NCT05427240) | Abramson Cancer Center at Penn Medicine | 2022-09-28 |
| Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women (NCT05499520) | Abramson Cancer Center at Penn Medicine | 2022-09-21 |
| SBRT With Atezo/Bev for HCC (NCT05488522) | Abramson Cancer Center at Penn Medicine | 2022-09-01 |